2007
DOI: 10.1007/s00595-006-3366-7
|View full text |Cite
|
Sign up to set email alerts
|

Axillary Lymph Node Echo-Guided Fine-Needle Aspiration Cytology Enables Breast Cancer Patients to Avoid a Sentinel Lymph Node Biopsy. Preliminary Experience and a Review of the Literature

Abstract: This simple, inexpensive, and minimally invasive technique makes it possible to avoid the additional cost of a sentinel lymph node biopsy while also sparing the patient the stress of undergoing a second surgery.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
37
3
5

Year Published

2009
2009
2019
2019

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 54 publications
(48 citation statements)
references
References 35 publications
3
37
3
5
Order By: Relevance
“…Concurrent with the surgical treatment of their primary breast cancer, the patient would undergo sentinel LN biopsy after chemotherapy [27]. Limitations of this practice include: 1) needle biopsy of a radiographically suspicious axillary LN can have a false-negative result of over 30% [28], and 2) the false-negative rate of sentinel LN biopsies after neoadjuvant chemotherapy is higher at 12% [29] compared to the desirable rate of <5% [30]. False-negative LN results may alter adjuvant systemic treatment recommendations and/or additional recommendations for locoregional control (subsequent axillary lymph node dissection/radiation therapy), potentially impacting care for some patients.…”
Section: Discussisonmentioning
confidence: 99%
“…Concurrent with the surgical treatment of their primary breast cancer, the patient would undergo sentinel LN biopsy after chemotherapy [27]. Limitations of this practice include: 1) needle biopsy of a radiographically suspicious axillary LN can have a false-negative result of over 30% [28], and 2) the false-negative rate of sentinel LN biopsies after neoadjuvant chemotherapy is higher at 12% [29] compared to the desirable rate of <5% [30]. False-negative LN results may alter adjuvant systemic treatment recommendations and/or additional recommendations for locoregional control (subsequent axillary lymph node dissection/radiation therapy), potentially impacting care for some patients.…”
Section: Discussisonmentioning
confidence: 99%
“…Consequently, 44 articles included information relating FNAC and breast cancer diagnosis. But only 21 of 44 articles satisfied the requirements of the meta-analysis fully (Bonnema et al, 1997;Bedrosian et al, 2003;Deurloo et al, 2003;Kuenen-Boumeester et al, 2003;Sapino et al, 2003;Duchesne et al, 2005;Podkrajsek et al, 2005;Popli et al, 2006;van Rijk et al, 2006;Altomare et al, 2007;Ciatto et al, 2007;Alkuwari et al, 2008;Tahir et al, 2008;Baruah et al, 2010;Jung et al, 2010;Luparia et al, 2010;Carroll et al, 2011;Devaraj et al, 2011;Hayes et al, 2011;Schiettecatte et al, 2011), addressing the value of FNAC in staging of axillary lymph node in breast cancer patients. The detailed procedure was seen in Figure 1.…”
Section: Literature Search and Selectionmentioning
confidence: 99%
“…AFNA is a simple, inexpensive, and minimally invasive technique that makes possible reduction in the numbers of SN biopsies performed [19] [20]. Previous studies have reported that the sensitivity of AFNA was low and the false-negative rate was high [7] [10] [19] [20]. In this study, all patients with AFNA+ findings had metastatic disease at ALND.…”
Section: Discussionmentioning
confidence: 64%
“…Accuracies of each examination were reported [9], with ultrasound found to be a suitable diagnostic tool for determining lymph node morphologic characteristics in the axilla, and histologic examination of lymph nodes, as well as sonographically guided AFNA [10]. AFNA is a simple, inexpensive, and minimally invasive technique that makes possible reduction in the numbers of SN biopsies performed [19] [20]. Previous studies have reported that the sensitivity of AFNA was low and the false-negative rate was high [7] [10] [19] [20].…”
Section: Discussionmentioning
confidence: 99%